<scp>m6A</scp>‐Mediated Methylation Patterns and Their Association With Obstructive Sleep Apnea in Lung Adenocarcinoma
Analyses confirmed m6A modification's role in LUAD progression, immune regulation, and outcomes. The m6A score is a valuable prognostic marker associated with survival, OSAHS incidence, and drug sensitivity. These findings highlight m6A's potential as a therapeutic target and biomarker, particularly for LUAD patients with OSAHS.
Authors
- Zhuodong Chai
- Xiaoying Wei
- Wei Yuan (ORCID: https://orcid.org/0000-0002-1122-6481)
- Lei Xia (ORCID: https://orcid.org/0000-0002-0409-6148)
- Daxiong Zeng (ORCID: https://orcid.org/0000-0002-6476-2974)
- Jing Li (ORCID: https://orcid.org/0000-0001-8170-0081)
- Junhong Jiang
Institutions
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
- Texas A&M University (US)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cnr2.70344
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81